Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 934 participants.
Also called NCT01121835
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 934 participants
- Sponsor
- Registry
-
NCT01121835 -
2009-018172-33
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Brazil, China, Colombia, Denmark, Greece, India, Italy, Kuwait, Mexico, Romania, South Korea, Spain, Taiwan, Türkiye, United Arab Emirates
- Registry status
- Completed
Technical summary
Registry record NCT01121835. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2012-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
- Acronym
- GALAPAGOS
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- INSULIN GLARGINE
- Intervention (Drug)
- INSULIN GLULISINE
- Intervention (Drug)
- PREMIXED INSULIN
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01121835- Content hash
9078d6097398ae2cf435fd9fce6e4472f47fbc17e2ffdc247d45a4480f224220